These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7278497)

  • 21. Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum.
    Consolo S; Ladinsky H; Garattini S
    J Pharm Pharmacol; 1974 Apr; 26(4):275-7. PubMed ID: 4151386
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Dopaminergic-cholinergic interaction in the striatum: decrease in rat striatal acetylcholine (ACh) levels by dopaminergic and cholinergic antagonists.
    Bianchi S; Consolo S; Ladinsky H
    Br J Pharmacol; 1974 Nov; 52(3):428P-429P. PubMed ID: 4458851
    [No Abstract]   [Full Text] [Related]  

  • 23. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels.
    Euvrard C; Ferland L; Di Paolo T; Beaulieu M; Labrie F; Oberlander C; Raynaud JP; Boissier JR
    Neuropharmacology; 1980 Apr; 19(4):379-86. PubMed ID: 7383283
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.
    Markstein R
    J Neural Transm; 1981; 51(1-2):39-59. PubMed ID: 6267192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine.
    Trabucchi M; Cheney DL; Racagni G; Costa E
    Brain Res; 1975 Feb; 85(1):130-4. PubMed ID: 1109691
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of striatal acetylcholine concentration by D2-dopamine receptors.
    Sethy VH
    Eur J Pharmacol; 1979 Dec; 60(4):397-8. PubMed ID: 43263
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
    DeBoer P; Abercrombie ED; Heeringa M; Westerink BH
    Brain Res; 1993 Apr; 608(2):198-203. PubMed ID: 8495354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 33. Age-related decrease in apomorphine modulation of acetylcholine release from rat striatal slices.
    Thompson JM; Makino CL; Whitaker JR; Joseph JA
    Brain Res; 1984 May; 299(1):169-73. PubMed ID: 6722565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of 3H-apomorphine binding by dopamine and bromocriptine.
    Robertson HA
    Eur J Pharmacol; 1980 Jan; 61(2):209-11. PubMed ID: 7353592
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL; Grewaal DS; McGeer EG
    Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
    Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone enhances the release of acetylcholine from cholinergic interneurons of the striatum if the dopaminergic input is impaired.
    Sándor NT; Kiss J; Sándor A; Lendvai B; Vizi ES
    Brain Res; 1991 Jun; 552(2):343-5. PubMed ID: 1913196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant.
    Ladinsky H; Consolo S; Garattini S
    Life Sci; 1974 Apr; 14(7):1251-60. PubMed ID: 4823638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.